Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse.

Hyde, J F

Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse. [electronic resource] - Journal of neuroendocrinology Jan 1996 - 9-15 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.

0953-8194

10.1111/j.1365-2826.1996.tb00681.x doi


Animals
Cerebral Cortex--metabolism
Estradiol--pharmacology
Growth Hormone--blood
Growth Hormone-Releasing Hormone--genetics
Humans
Hypothalamo-Hypophyseal System--drug effects
Hypothalamus--metabolism
Male
Mice
Mice, Transgenic
Pituitary Gland, Anterior--cytology
Prolactin--blood
RNA, Messenger--genetics
Vasoactive Intestinal Peptide--metabolism